Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

ClinicalTrials.gov ID: NCT00267267

Public ClinicalTrials.gov record NCT00267267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Open-Label, Multi-Center, Double-Blind, Randomized, Parallel Group Study Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin, Administered Once Daily (QD) Compared to Fixed Combination Ezetimibe/Simvastatin for 6 Weeks in Subjects With Dyslipidemia.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of combination cholesterol medications to see how the different treatments compare to one another.

Study identification

NCT ID
NCT00267267
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,784 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
Not listed
Completion
Dec 31, 2006
Last update posted
Dec 9, 2007

2006 – 2007

United States locations

U.S. sites
123
U.S. states
34
U.S. cities
103
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35209-7802
Pfizer Investigational Site Birmingham Alabama 35235
Pfizer Investigational Site Chandler Arizona 85224
Pfizer Investigational Site Mesa Arizona 85201
Pfizer Investigational Site Jonesboro Arkansas 72401
Pfizer Investigational Site Anaheim California 92804
Pfizer Investigational Site Escondido California 92025-4284
Pfizer Investigational Site Fresno California 93720
Pfizer Investigational Site Los Altos California 94024
Pfizer Investigational Site Los Angeles California 90015
Pfizer Investigational Site Palm Springs California 92262
Pfizer Investigational Site Paramount California 90723
Pfizer Investigational Site San Diego California 92128
Pfizer Investigational Site Santa Rose California 95405
Pfizer Investigational Site Walnut Creek California 94598
Pfizer Investigational Site Westlake Village California 91361
Pfizer Investigational Site Golden Colorado 80401
Pfizer Investigational Site New Haven Connecticut 06519-1600
Pfizer Investigational Site Newark Delaware 19713
Pfizer Investigational Site Washington D.C. District of Columbia 20010
Pfizer Investigational Site Atlantis Florida 33462
Pfizer Investigational Site Boca Raton Florida 33486
Pfizer Investigational Site Daytona Beach Florida 32114
Pfizer Investigational Site DeFuniak Springs Florida 32435
Pfizer Investigational Site Destin Florida 32541
Pfizer Investigational Site Lakeland Florida 33805
Pfizer Investigational Site Miami Florida 33136
Pfizer Investigational Site Miami Florida 33144
Pfizer Investigational Site Miami Florida 33173
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Pensacola Florida 32504-8721
Pfizer Investigational Site Atlanta Georgia 30309
Pfizer Investigational Site Atlanta Georgia 30328
Pfizer Investigational Site Atlanta Georgia 30342
Pfizer Investigational Site Honolulu Hawaii 96814
Pfizer Investigational Site Aurora Illinois 60504
Pfizer Investigational Site Chicago Illinois 60637
Pfizer Investigational Site Rockford Illinois 61108
Pfizer Investigational Site Springfield Illinois 62701
Pfizer Investigational Site Evansville Indiana 47712
Pfizer Investigational Site Evansville Indiana 47713
Pfizer Investigational Site Evansville Indiana 47714
Pfizer Investigational Site Des Moines Iowa 50314
Pfizer Investigational Site Newton Kansas 67114
Pfizer Investigational Site Overland Park Kansas 66210
Pfizer Investigational Site Pratt Kansas 67124
Pfizer Investigational Site Topeka Kansas 66606
Pfizer Investigational Site Edgewood Kentucky 41017
Pfizer Investigational Site Erlanger Kentucky 41018
Pfizer Investigational Site Louisville Kentucky 40205-3374
Pfizer Investigational Site Columbia Maryland 21044-2914
Pfizer Investigational Site Ayer Massachusetts 01432
Pfizer Investigational Site Boston Massachusetts 02111
Pfizer Investigational Site Boston Massachusetts 02114
Pfizer Investigational Site Milford Massachusetts 01757
Pfizer Investigational Site Bloomfield Hills Michigan 48302
Pfizer Investigational Site Grand Rapids Michigan 49525
Pfizer Investigational Site Troy Michigan 48098
Pfizer Investigational Site Brooklyn Center Minnesota 55430
Pfizer Investigational Site Edina Minnesota 55435
Pfizer Investigational Site Saint Cloud Minnesota 56303-1901
Pfizer Investigational Site Columbia Missouri 65212
Pfizer Investigational Site Jefferson City Missouri 65109
Pfizer Investigational Site Manchester Missouri 63021
Pfizer Investigational Site Springfield Missouri 65804
Pfizer Investigational Site Springfield Missouri 65807
Pfizer Investigational Site Omaha Nebraska 68106
Pfizer Investigational Site Omaha Nebraska 68114
Pfizer Investigational Site Omaha Nebraska 68130
Pfizer Investigational Site Las Vegas Nevada 89106
Pfizer Investigational Site Las Vegas Nevada 89128
Pfizer Investigational Site Cooperstown New York 13326
Pfizer Investigational Site Endwell New York 13760
Pfizer Investigational Site Lewiston New York 14092
Pfizer Investigational Site Manlius New York 13104
Pfizer Investigational Site Rochester New York 14609
Pfizer Investigational Site Rochester New York 14618
Pfizer Investigational Site Syracuse New York 13202
Pfizer Investigational Site West Seneca New York 14224
Pfizer Investigational Site Cary North Carolina 27511
Pfizer Investigational Site Charlotte North Carolina 28209-3734
Pfizer Investigational Site Huntersville North Carolina 28078
Pfizer Investigational Site Monroe North Carolina 28112
Pfizer Investigational Site Raleigh North Carolina 27609
Pfizer Investigational Site Wilmington North Carolina 28412
Pfizer Investigational Site Winston-Salem North Carolina 27103-3315
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Cleveland Ohio 44195
Pfizer Investigational Site Fairview Park Ohio 44126
Pfizer Investigational Site Beaver Pennsylvania 15009
Pfizer Investigational Site Bensalem Pennsylvania 19020
Pfizer Investigational Site Doylestown Pennsylvania 18901
Pfizer Investigational Site Harleysville Pennsylvania 19438
Pfizer Investigational Site Lancaster Pennsylvania 17603
Pfizer Investigational Site Pittsburgh Pennsylvania 15213
Pfizer Investigational Site Pittsburgh Pennsylvania 15224
Pfizer Investigational Site Sayre Pennsylvania 18840
Pfizer Investigational Site Lincoln Rhode Island 02865
Pfizer Investigational Site Providence Rhode Island 02906
Pfizer Investigational Site Anderson South Carolina 29621
Pfizer Investigational Site Mt. Pleasant South Carolina 29464
Pfizer Investigational Site Simpsonville South Carolina 29681
Pfizer Investigational Site Bristol Tennessee 37620
Pfizer Investigational Site Chattanooga Tennessee 37404
Pfizer Investigational Site Germantown Tennessee 38138
Pfizer Investigational Site Johnson City Tennessee 37601
Pfizer Investigational Site Memphis Tennessee 38104
Pfizer Investigational Site Memphis Tennessee 38119
Pfizer Investigational Site Memphis Tennessee 38120
Pfizer Investigational Site Memphis Tennessee 38128
Pfizer Investigational Site Selmer Tennessee 38375
Pfizer Investigational Site Arlington Texas 76017
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Houston Texas 77054
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site San Antonio Texas 78238
Pfizer Investigational Site Bountiful Utah 84010
Pfizer Investigational Site Salt Lake City Utah 84102
Pfizer Investigational Site Newport News Virginia 23606
Pfizer Investigational Site Norfolk Virginia 23502
Pfizer Investigational Site Renton Washington 98055
Pfizer Investigational Site Spokane Washington 99216

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00267267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2007 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00267267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →